{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:21:01Z","timestamp":1757542861301},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1981,1,1]],"date-time":"1981-01-01T00:00:00Z","timestamp":347155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1981]]},"DOI":"10.1007\/bf00544582","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T14:50:38Z","timestamp":1100875838000},"page":"329-333","source":"Crossref","is-referenced-by-count":5,"title":["Plasma propranolol steady state concentrations in thyroid disorders"],"prefix":"10.1007","volume":"19","author":[{"given":"J.","family":"Feely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. H.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2125.1977.tb00672.x","volume":"4","author":"JM Bell","year":"1977","unstructured":"Bell JM, Russell CJ, Nelson JK, Kelly JG, McDevitt DG (1977) Studies on the effect of thyroid dysfunction on the elimination of ?-adrenoreceptor blocking drugs. Br J Clin Pharmacol 4: 79?82","journal-title":"Br J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","unstructured":"Bloxham DL, Curzon G, Hutson PH (1977) A simple small volume ultrafiltration apparatus applicable to protein binding studies. Br J Clin Pharmacol 4: 405 (P)","DOI":"10.1111\/j.1365-2125.1977.tb00751.x"},{"key":"CR3","doi-asserted-by":"crossref","unstructured":"Borga O, Odar-Cederlof I, Piafsky KM, Sjoqvist F (1977) Plasma protein binding of propranolol in disease states. Br J Clin Pharmacol 4: 627p","DOI":"10.1111\/j.1365-2125.1977.tb00799.x"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.1979.tb00896.x","volume":"7","author":"CM Castleden","year":"1979","unstructured":"Castleden CM, George CF (1979) The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol 7: 49?54","journal-title":"Br J Clin Pharmacol"},{"key":"CR5","first-page":"156","volume":"49","author":"J Crooks","year":"1973","unstructured":"Crooks J, Hedley AJ, MacNee C, Stevenson IH (1973) Change in drug metabolism activity in thyroid disease. Br J Pharmacol 49: 156?157","journal-title":"Br J Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00003088-197601050-00002","volume":"1","author":"M Eichelbaum","year":"1976","unstructured":"Eichelbaum M (1976) Drug metabolism in thyroid disease. Clin Pharmacokinet 1: 339?350","journal-title":"Clin Pharmacokinet"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM197702032960509","volume":"296","author":"M Eriksson","year":"1977","unstructured":"Eriksson M, Rubenfeld S, Garber AJ, Kohler PO (1977) Propranolol does not prevent thyroid storm. N Engl J Med 296: 263?264","journal-title":"N Engl J Med"},{"key":"CR8","first-page":"114","volume":"186","author":"GH Evans","year":"1973","unstructured":"Evans GH, Nies AS, Shand DG (1973) The disposition of propranolol III Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. J Pharmacol Exp Ther 186: 114?122","journal-title":"J Pharmacol Exp Ther"},{"key":"CR9","doi-asserted-by":"crossref","unstructured":"Feely J, Stevenson IH (1978) The effect of age and hyperthyroidism on plasma propranolol steady state concentrations. Br J Clin Pharmacol 6: 446P","DOI":"10.1016\/B978-0-08-023768-8.51908-3"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/jcem-51-3-658","volume":"51","author":"J Feely","year":"1980","unstructured":"Feely J, Forrest A, Gunn A, Hamilton W, Stevenson IH, Crooks J (1980) Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab 51: 658?661","journal-title":"J Clin Endocrinol Metab"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.2042-7158.1975.tb10231.x","volume":"27","author":"KF Illet","year":"1975","unstructured":"Illet KF, Hughes IE, Jellett JB (1975) The use of Kanamycin in equilibrium dialysis at 37\u00b0C. J Pharm Pharmacol 27: 861?863","journal-title":"J Pharm Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2125.1978.tb00836.x","volume":"6","author":"JG Kelly","year":"1978","unstructured":"Kelly JG, McDevitt DG (1978) Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol 6: 123?127","journal-title":"Br J Clin Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00000658-197306000-00025","volume":"177","author":"TC Lee","year":"1973","unstructured":"Lee TC, Coffey RJ, Mackin J, Cobb M, Routon J, Canary JJ (1973) The use of propranolol in the surgical treatment of thyrotoxic patients, Ann Surg 177: 643?647","journal-title":"Ann Surg"},{"key":"CR14","first-page":"715","volume":"141","author":"JG Ljunggren","year":"1975","unstructured":"Ljunggren JG, Persson B (1975) Pre-operative treatment of thyrotoxicosis with a beta-adrenergic blocking agent. Acta Clin Scand 141: 715?718","journal-title":"Acta Clin Scand"},{"key":"CR15","first-page":"42","volume":"8","author":"C MacNee","year":"1972","unstructured":"MacNee C, Hedley AJ, Adamson DG, Crooks J (1972) Drug metabolising capacity in thyroid disease. Isr J Med Sci 8: 42?43","journal-title":"Isr J Med Sci"},{"key":"CR16","first-page":"1010","volume":"1","author":"W Michie","year":"1974","unstructured":"Michie W, Hamer-Hodges DW, Pegg CAS, Orr FGC, Bewsher PD (1974) Beta-blockers and partial thyroidectomy for thyrotoxicosis. Lancet 1: 1010?1011","journal-title":"Lancet"},{"key":"CR17","doi-asserted-by":"crossref","unstructured":"Riddell JG, Neill JD, Kelly JG, McDevitt DG (1979) Propranolol kinetics in hyperthyroidism. Br J Clin Pharmacol 8: 386p","DOI":"10.1111\/j.1365-2125.1979.tb04733.x"},{"key":"CR18","doi-asserted-by":"crossref","unstructured":"Riddell JG, Neill JD, Kelly JG, McDevitt DG (1980) The kinetics of propranolol in hypothyroidism. Br J Clin Pharmacol 9: 121p","DOI":"10.1111\/j.1365-2125.1980.tb04823.x"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00003088-197904020-00001","volume":"4","author":"PA Routledge","year":"1979","unstructured":"Routledge PA, Shand DG (1979) Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 4: 73?90","journal-title":"Clin Pharmacokinet"},{"key":"CR20","unstructured":"Rubenfeld S, Silverman VE, Welch KMA, Mallette LE, Kohler PO (1978) Propranolol pharmacokinetics in thyrotoxicosis. Clin Res 26: 295A"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197902153000707","volume":"300","author":"S Rubenfeld","year":"1979","unstructured":"Rubenfeld S, Silverman VE, Welch KMA, Mallette LE, Kohler PO (1979) Variable plasma propranolol levels in thyrotoxicosis. N Engl J Med 300: 353?354","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cpt1977226853","volume":"22","author":"E Vervloet","year":"1977","unstructured":"Vervloet E, Pluym BFM, Cilissen J, Kohlen K, Merkus FWHM (1977) Propranolol serum levels during twenty-four hours. Clin Pharmacol Ther 22: 853?857","journal-title":"Clin Pharmacol Ther"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cpt19792618","volume":"26","author":"RE Vestal","year":"1979","unstructured":"Vestal RE, Wood AJJ, Branch RA, Shand DG, Wilkinson GR (1979) Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 26: 8?15","journal-title":"Clin Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/jps.2600631212","volume":"63","author":"T Walle","year":"1974","unstructured":"Walle T (1974) GLC determination of propranolol, other ?-blocking drugs and metabolites in biological fluids and tissues. J Pharm Sci 63: 1885?1891","journal-title":"J Pharm Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cpt1978246668","volume":"24","author":"T Walle","year":"1979","unstructured":"Walle T, Conradi EC, Walle UK, Fagan TC, Gaffney TE (1979) The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther 24: 668?677","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00544582\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T05:56:44Z","timestamp":1585979804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00544582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981]]}},"alternative-id":["BF00544582"],"URL":"https:\/\/doi.org\/10.1007\/bf00544582","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981]]}}}